Osteoporosis medications and your dental health

Journal of the American Dental Association

Volumn 142, Issue 11, 2011, Pages 1320-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85046981131     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2011.0119     Document Type: Short Survey

References (4)

1. National Osteoporosis Foundation. Bone health basics: why bone health is important, "www.nof.org/aboutosteoporosis/bonebasics/whybonehealth". Accessed Sept. 30, 2011.
2. Bauer DC, Black DM, Garnero P, et al. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J Bone Miner Res 2004;19(8):1250-1258. (Pubitemid 41094365)
3. Silverman SL, Watts NB, Delmas PD, Lange JL, Lindsay R. Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. Osteoporos Int 2007;18(1):25-34. (Pubitemid 44885493)
4. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 2001;344(5):333-340. (Pubitemid 32107641)